期刊
PLOS ONE
卷 7, 期 3, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0033534
关键词
-
资金
- Ministerio de Ciencia e Innovacion, Spain [SAF2008-02042, SAF2011-22463, BFU2009-07206, SAF-2008-03685, SAF2011-27261]
- Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain [FMV-UC 08/02]
- European Commission [ISCIII-FIS06/1502]
- Junta de Andalucia
- Consejeria de Economia
- Innovacion y Ciencia [CVI-226, PC08-CTS-04046]
- Fundacion Eugenio Rodriguez Pascual
- JAE-Doc-CSIC
CD38, a type II transmembrane glycoprotein expressed in many cells of the immune system, is involved in cell signaling, migration and differentiation. Studies in CD38 deficient mice (CD38 KO mice) indicate that this molecule controls inflammatory immune responses, although its involvement in these responses depends on the disease model analyzed. Here, we explored the role of CD38 in the control of autoimmune responses using chicken collagen type II (col II) immunized C57BL/6-CD38 KO mice as a model of collagen-induced arthritis (CIA). We demonstrate that CD38 KO mice develop an attenuated CIA that is accompanied by a limited joint induction of IL-1 beta and IL-6 expression, by the lack of induction of IFN gamma expression in the joints and by a reduction in the percentages of invariant NKT (iNKT) cells in the spleen. Immunized CD38 KO mice produce high levels of circulating IgG1 and low of IgG2a anti-col II antibodies in association with reduced percentages of Th1 cells in the draining lymph nodes. Altogether, our results show that CD38 participates in the pathogenesis of CIA controlling the number of iNKT cells and promoting Th1 inflammatory responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据